Get the Stockscreener App
2.40
0.84%
0.02
Edesa Biotech Inc stock is traded at $2.40, with a volume of 27,900.
It is up +0.84% in the last 24 hours and down -1.23% over the past month.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
See More
Previous Close:
$2.38
Open:
$2.41
24h Volume:
27,900
Relative Volume:
1.01
Market Cap:
$16.89M
Revenue:
-
Net Income/Loss:
$-7.72M
P/E Ratio:
-0.9093
EPS:
-2.6394
Net Cash Flow:
$-6.25M
1W Performance:
+7.38%
1M Performance:
-1.23%
6M Performance:
-1.23%
1Y Performance:
-46.07%
1-Day Range:
$2.33
$2.45
1-Week Range:
$2.22
$2.48
52-Week Range:
$1.55
$5.00
Edesa Biotech Inc Stock (EDSA) Company Profile
Name
Edesa Biotech Inc
Sector
Industry
Phone
(905) 475-1234
Address
100 SPY COURT, MARKHAM, ON
Compare EDSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
2.40 | 15.99M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Edesa Biotech Inc Stock (EDSA) Latest News
Is Edesa Biotech Inc. stock bottoming outEarnings Performance Report & Risk Controlled Swing Alerts - Newser
Can technical indicators confirm Edesa Biotech Inc.’s reversalJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - Newser
Understanding Edesa Biotech Inc.’s price movementQuarterly Trade Review & Capital Efficient Trade Techniques - Newser
Statistical indicators supporting Edesa Biotech Inc.’s strengthJuly 2025 Review & Weekly Stock Performance Updates - Newser
Risk vs reward if holding onto Edesa Biotech Inc.New Guidance & Verified Momentum Stock Watchlist - Newser
Edesa Biotech Inc. stock trend outlook and recovery pathJuly 2025 Opening Moves & Stock Market Timing Techniques - Newser
Detecting support and resistance levels for Edesa Biotech Inc.Portfolio Value Report & Safe Entry Trade Signal Reports - Newser
Top chart patterns to watch in Edesa Biotech Inc.Weekly Investment Recap & Risk Controlled Daily Trade Plans - Newser
Price action breakdown for Edesa Biotech Inc.Weekly Trade Recap & Fast Entry High Yield Tips - Newser
Live Scanner Shows Breakout on Edesa Biotech Inc.July 2025 Update & Fast Moving Trade Plans - sundaytimes.kr
How Resilient Is Edesa Biotech Inc. Stock During Economic DownturnsTrade Volume Summary & Daily Stock Trend Watchlist - Newser
Zacks Small Cap Reduces Earnings Estimates for Edesa Biotech - Defense World
Tools to monitor Edesa Biotech Inc. recovery probability2025 EndofYear Setup & Expert Verified Movement Alerts - Newser
Edesa Biotech Inc. stock chart pattern explained2025 Retail Activity & Reliable Trade Execution Plans - Newser
How hedge fund analytics apply to Edesa Biotech Inc. stockTrade Risk Assessment & Consistent Growth Equity Picks - Newser
How to track smart money flows in Edesa Biotech Inc.Market Growth Review & Consistent Profit Focused Trading Strategies - Newser
Real time alert setup for Edesa Biotech Inc. performanceGold Moves & Free AI Powered Buy and Sell Recommendations - Newser
How sentiment analysis helps forecast Edesa Biotech Inc.Portfolio Return Report & Low Drawdown Trading Techniques - Newser
Is Edesa Biotech Inc. undervalued by DCF analysisQuarterly Earnings Summary & High Return Trade Guides - sundaytimes.kr
How to build a custom watchlist for Edesa Biotech Inc.Portfolio Risk Summary & Growth Focused Stock Reports - Newser
Why is Edesa Biotech Inc. stock going up2025 Valuation Update & Risk Controlled Swing Trade Alerts - thegnnews.com
Edesa Biotech Inc. Included in Top Momentum ScanMarket Risk Summary & Community Consensus Trade Signals - 선데이타임즈
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Edesa Biotech Inc. Earnings Report Breakdown: What Investors Should Know2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
EDSA: EB06 Manufacturing to be Completed by End of 2025… - Zacks Small Cap Research
Edesa Biotech Inc. Reaches Critical Trendline SupportWall Street Watch & Reliable Price Action Trade Plans - beatles.ru
Can momentum traders help lift Edesa Biotech Inc.Weekly Trade Summary & Free AI Powered Buy and Sell Recommendations - Newser
Edesa Biotech Posts Narrower Loss in Q3 - AOL.com
How Edesa Biotech Inc. stock performs during market volatilitySmart Trade Forecast Based on Neural Logic - Newser
Edesa Biotech: A Narrowing Loss and Strategic Focus Signal Growing Momentum in Dermatology Innovation - AInvest
Will Edesa Biotech Inc. stock go up soonStock Entry Point Planner with Volume Spike - Newser
Edesa Biotech's Strategic Reorientation and Financial Resilience: A Path to Dermatology Sector Growth - AInvest
Edesa Biotech Inc Stock (EDSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):